Acyclovir dose for suppressive therapy

effective for suppressive and episodic therapy. Valacyclovir is the prodrug of acyclovir, and has improved oral bioavailability, with decreased dosing frequency, compared to acyclovir. When deciding on suppressive therapy for genital HSV-2 infection in persons with HIV and HSV-2 coinfection, factors to consider include

We use acyclovir 400 mg three times daily as suppressive therapy. Doses for suppressive therapy are higher in pregnant compared with nonpregnant women because

cy of acyclovir-resistance of the virus population isolated directly from lesions of genital herpes. This finding suggests that long-term, low-dose acyclovir suppressive therapy for Antiviral Chemistry Chemotherapy 3 239 Effect of long-term, low-dose acyclovir suppressive therapy on susceptibility to acyclovir and frequency of

Daily Suppressive Therapy: Acyclovir 400mg bid or acyclovir 200mg PO 3-5 times a day. (The goal of the 200-mg regimen is to identify the lowest dose that

herpes outbreaks would be suppressive therapy with antiviral medication such as acyclovir or valacyclovir. Usually a low dose is given daily

acyclovir-suppressive therapy. Thus, the low dose of acyclovir suppressive therapy did not affect the susceptibility to acyclovir or increase the fre-quency of acyclovir-resistant viruses in the geni-tal lesions. Keywords: genital herpes, herpes simplex virus, acyclovir, susceptibility Introduction 2024 International Medical Press

Effect of Long-Term, Low-Dose Acyclovir Suppressive Therapy on Susceptibility to Acyclovir and Frequency of Acyclovir Resistance of Herpes Simplex Virus Type 2

The acyclovir dose when used as suppressive therapy is 400 mg Prophylactic acyclovir also has been used to prevent reactivation of herpes labialis following

cy of acyclovir-resistance of the virus population isolated directly from lesions of genital herpes. This finding suggests that long-term, low-dose acyclovir suppressive therapy for Antiviral Chemistry Chemotherapy 3 239 Effect of long-term, low-dose acyclovir suppressive therapy on susceptibility to acyclovir and frequency of